Honoring the Legacy of Professor Li-He Zhang on His 80th Birthday
Imagine if the key to treating diseases like diabetes, HIV, and cancer wasn't a complex synthetic chemical, but a cleverly disguised version of something found in nature: a sugar molecule.
This is the world of glycobiology and carbohydrate-based drug discoveryâa field profoundly advanced by the pioneering work of Professor Li-He Zhang. As we celebrate his 80th birthday, we explore the sweet science of how mimicking nature's building blocks can lead to life-saving medicines.
For decades, biology has been obsessed with the central dogma: DNA â RNA â Protein. But there's another, more subtle language written on the surface of every cell in your bodyâthe Sugar Code. Complex carbohydrates, or glycans, coat our cells like a dense forest, acting as identification cards, gatekeepers, and communication hubs.
Viruses, bacteria, and even our own immune systems "read" these sugars to know which cells to infect, attack, or ignore. The enzymes that build (glycosyltransferases) and break down (glycosidases) these sugar chains are the scribes and editors of this language. If we could interfere with these enzymes, we could potentially stop a pathogen in its tracks or correct a cellular miscommunication that leads to disease.
The human body produces over 10,000 different complex sugar structures that play crucial roles in cellular communication and immunity.
This is where Professor Zhang's work becomes pivotal. His research focused on designing and synthesizing "molecular mimics"âcompounds that look like natural sugars to these enzymes but are actually cleverly crafted inhibitors that block their action.
One of the most successful classes of these mimics is imino sugars. These are molecules where a oxygen atom in the sugar ring is replaced by a nitrogen atom. This small change creates a "Trojan Horse": the molecule still looks like a sugar to the enzyme, but the nitrogen gives it a positive charge, causing it to bind much more tightly and jam the enzyme's machinery.
A flagship achievement in Professor Zhang's lab was the development of novel and efficient methods to synthesize these complex imino sugars, particularly a famous one called 1-deoxynojirimycin (DNJ) and its derivatives. DNJ is the parent compound of a successful diabetes drug, but its potential stretches far further.
Standard glucose molecule with oxygen atoms (red)
1-deoxynojirimycin (DNJ) with nitrogen atom (blue) replacing oxygen
Creating these molecules in the lab is a feat of organic chemistry. Professor Zhang's group developed elegant, multi-step synthetic pathways to build DNJ from simpler starting materials. Here's a simplified look at one such process.
The goal is to build the complex, nitrogen-containing ring structure with all the correct chemical groups (OH groups) in the right spatial orientation. One common strategy involves:
Often, a cheap and readily available sugar like glucose or fructose is chosen as the starting template.
The various reactive OH groups on the sugar are temporarily "capped" with protecting groups (like benzyl rings) to prevent them from reacting in the wrong steps.
A key step is transforming a specific part of the sugar molecule into an amino group (-NHâ).
Through a series of chemical reactions, the linear chain is manipulated to form the stable, six-membered imino sugar ring.
Finally, all the protecting groups are carefully removed to reveal the final, functional DNJ molecule.
Once synthesized, the new molecules are put to the test. They are incubated with various glycosidase enzymes, and their ability to inhibit the enzyme's activity is measured, yielding an ICâ â value (the concentration of inhibitor needed to reduce enzyme activity by 50%). A lower ICâ â means a more potent inhibitor.
The results from Professor Zhang's lab consistently showed that his synthetically optimized DNJ derivatives were powerful and selective inhibitors.
This wasn't just about making a molecule; it was about proving that synthetic chemistry could improve upon nature. By tweaking the structure, his team could "tune" the inhibitor to be more specific for a particular enzyme, thereby increasing its potential as a drug and reducing side effects.
ICâ â values in micromolar (μM). Lower value = stronger inhibition.
Compound Name | α-glucosidase (a diabetes target) | α-mannosidase (a viral target) | β-glucosidase (a metabolic disease target) |
---|---|---|---|
1-deoxynojirimycin (DNJ) | 25 μM | 150 μM | 45 μM |
Prof. Zhang's Derivative A | 5 μM | 140 μM | 40 μM |
Prof. Zhang's Derivative B | 30 μM | 22 μM | 180 μM |
This data demonstrates how chemical modification can selectively enhance activity against a specific disease target.
Compound | Primary Enzyme Target | Potential Therapeutic Application |
---|---|---|
Miglitol (based on DNJ) | α-glucosidase (intestinal) | Type 2 Diabetes (delays carbohydrate digestion) |
Prof. Zhang's Derivative B | α-mannosidase I (endoplasmic reticulum) | Antiviral Therapy (e.g., against HIV, Dengue) |
Prof. Zhang's Derivative C | β-glucocerebrosidase | Gaucher's Disease (a lysosomal storage disorder) |
A simplified overview of a synthetic pathway, showing the efficiency of each major step.
Synthesis Step | Reaction Type | Product Formed | Yield (%) |
---|---|---|---|
1. Starting Material | - | D-Glucose | - |
2. Protection | Benzylation | Fully protected glucose | 85% |
3. Key Amination | Nucleophilic Substitution | Amino-intermediate | 78% |
4. Cyclization | Ring-closing | Protected DNJ ring | 65% |
5. Final Deprotection | Hydrogenation | Pure 1-deoxynojirimycin (DNJ) | 90% |
The groundbreaking synthesis of these molecules relies on a suite of specialized tools and reagents. Here are some essentials from a carbohydrate chemist's lab bench:
Research Reagent / Material | Function in Imino Sugar Synthesis |
---|---|
Protected Sugar Scaffolds (e.g., benzylated glucose) | The starting building block; protecting groups allow chemists to control which part of the molecule reacts and when. |
Azide Reagents (e.g., NaNâ, DPPA) | A safe way to introduce nitrogen into the molecule. The azide group (-Nâ) is later reduced to the crucial amino group (-NHâ). |
Catalysts (e.g., Pd/C, Pd(OH)â) | Precious metal catalysts used in the final "deprotection" step to remove benzyl groups via hydrogenation, revealing the final product. |
Anhydrous Solvents (e.g., THF, DMF) | Many key reactions are extremely sensitive to water. These dry solvents ensure the reactions proceed correctly and efficiently. |
Chiral Chromatography Columns | Imino sugars are chiral molecules (like hands). These specialized columns are used to separate the desired "right-handed" molecule from its mirror image, which is crucial for drug activity. |
Professor Li-He Zhang's career is a testament to the power of fundamental organic chemistry to drive medical innovation. His meticulous work in synthesizing and understanding imino sugars provided the foundational knowledge and the physical compounds that allowed biologists and pharmacologists around the world to explore new therapeutic avenues.
His legacy is not just in the molecules he created, but in the generations of scientists he mentored and the entire field he helped elevate. The "Sugar Code" is now a major frontier in drug discovery, and it is pioneers like Professor Zhang who gave us the first cipher to break it.
Happy 80th Birthday, Professor Zhang. Thank you for making the world a sweeterâand healthierâplace.
Professor Zhang's work has inspired new approaches to drug discovery targeting carbohydrate-processing enzymes.